Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 21, 2022

SELL
$42.05 - $47.77 $12,615 - $14,331
-300 Closed
0 $0
Q1 2022

May 05, 2022

SELL
$40.23 - $47.74 $12,068 - $14,322
-300 Reduced 50.0%
300 $13,000
Q2 2021

Jul 27, 2021

SELL
$36.52 - $41.46 $7,304 - $8,292
-200 Reduced 25.0%
600 $24,000
Q1 2020

May 01, 2020

SELL
$32.47 - $48.83 $4,870 - $7,324
-150 Reduced 15.79%
800 $30,000
Q4 2019

Jan 28, 2020

SELL
$42.0 - $48.25 $15,288 - $17,563
-364 Reduced 27.7%
950 $45,000
Q3 2019

Oct 28, 2019

BUY
$40.46 - $43.52 $14,727 - $15,841
364 Added 38.32%
1,314 $56,000
Q3 2017

Oct 16, 2017

BUY
$39.44 - $41.55 $37,468 - $39,472
950
950 $38,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $67.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Hartford Financial Management Inc. Portfolio

Follow Hartford Financial Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Financial Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hartford Financial Management Inc. with notifications on news.